US Onychomycosis Market Research Report: Information By Type (Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Endonyx Onychomycosis (EO), And Others), By Treatment (Oral And Topical) And By Region (US) –Market Forecast Till 2032

1 Introduction

1.1 Onychomycosis: An Overview

1.2 Scope of Study

1.2.1 Research Objective

1.3 Market Structure

1.4 Types of Onychomycosis

1.5 Signs and Symptoms

1.5.1 Symptoms of Onychomycosis Nail Infection Based on Subtype

1.6 Cause

1.7 Treatments for Onychomycosis

2 Research Methodolgy

2.1 Primary Research

2.2 Secondary Research

3 Market Dynamics

3.1 Growth Drivers

3.1.1 Rising Per-capita Healthcare Expenditure

3.1.2 Increasing Diabetic Patients

3.1.3 Increasing Prevalence of Peripheral Artery Disease (PAD)

3.2 Challenges

3.2.1 Low awareness

3.2.2 Side effects

4 US Onychomycosis

4.1 US Onychomycosis Market

4.1.1 US Onychomycosis Market By Prevalence

4.1.2 US Nail Care Market

4.2 US Jublia Drug Market

4.3 US Kerydin Drug market

4.4 US Generic Drugs Market

5 Competitive Landscape

5.1 Market Share Analysis

6 Company Profile

6.1 Novartis

6.1.1 Overview

6.1.2 Product/Business Segment Overview

6.1.3 Financial Updates

6.1.4 Key Developments

6.2 Anacor Pharmaceuticals

6.2.1 Overview

6.2.2 Financial Updates

6.2.3 Key Developments

6.3 Johnson and Johnson

6.3.1 Overview

6.3.2 Product/Business Segment Overview

6.3.3 Financial Updates

6.3.4 Key Developments

6.4 Valeant Pharmaceuticals

6.4.1 Overview

6.4.2 Product/Business Segment Overview

6.4.3 Financial Updates

6.4.4 Key Developments

7 List of Tables

TABLE 1 TABLE FOR IDENTIFYING TYPES OF ONYCHOMYCOSIS 8

TABLE 2 US ONYCHOMYCOSIS MARKET, BY TYPES US$ (MILLION) 16

TABLE 3 US NAIL CARE MARKET, BY MAJOR DRUGS US$(MILLION) 17

TABLE 4 US JUBLIA DRUG MARKET, BY VALUE US$(MILLION) 18

TABLE 5 US JUBLIA DRUG MARKET, BY ASP ($) 18

TABLE 6 US JUBLIA DRUG MARKET BY VOLUME 19

TABLE 7 US KERYDIN DRUG MARKET BY VALUE US$ (MILLION) 19

TABLE 8 US KERYDIN DRUG MARKET, BY ASP ($) 19

TABLE 9 US KERYDIN DRUG MARKET BY VOLUME 20

TABLE 10 US GENERIC DRUG MARKET BY VALUE US$ (BILLION) 20

TABLE 11 US ONYCHOMYCOSIS MAJOR PLAYERS: 2020 (% SHARE) 21

8 List of Figures

FIGURE 1 RESEARCH PROCESS 11

FIGURE 2 US ONYCHOMYCOSIS MAJOR PLAYERS: 2020 (% SHARE) 21